.Merck trumps earnings desires, increases sales overview on tough need for best medicines like Keytruda CNBCMerck & Co. (MRK US) Trumps Revenue Estimates as Keytruda Sales Increase BloombergMerck Sell: Pharma Titan Posts Powerful End Results, However Expectation Falls Short Capitalist's Business DailyMerck Announces Second-Quarter 2024 Financial End results Yahoo FinanceMerck defeats earnings and also sales desires amidst Keytruda advantage, but supplies blended full-year outlook MarketWatch.